Ann: Company Update, page-111

Who's going to be paid what is pure speculation.
One thing that is a fact is the Acromegaly guru himself Professor Peter J Trainer says Atl 1103 is looking to have the goods over the others as far as Acromegaly is concerned.
I'm sure that this is recognized by all doing dd and that they realize the potential also if there is competition from more than one pharmaceutical company for our drug we'll get the best possible price.
I reckon that is a major selling point going forward into phase 3.
I'm also assuming that not all drugs would have the same expenses going thru the various phases.
just my opinion for what it's worth.